Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’
AI-generated summary Anthropic disclosed its acquisition of Mithril Medicine and Coefficient Bio as part of its growing life sciences and drug discovery initiatives. Eric Kauderer-Abrams says the internal pipeline will focus on rare, tropical and neglected diseases using Claude and AI agents.